←Back to Expert Scholars
Translational Medicine / 转化医学Colorectal Cancer, KRAS Targeted Therapy
Sarah Henrich
MD
🏢Memorial Sloan Kettering Cancer Center🌐USA
Associate Professor of Gastrointestinal Oncology
40
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Sarah Henrich investigates KRAS G12C inhibitor biology and resistance in colorectal cancer. Her group has explored combination strategies with EGFR inhibitors and developed translational trials for KRAS mutant CRC.
Share:
🧪Research Fields 研究领域
KRAS G12C inhibitors
sotorasib
adagrasib
resistance mechanisms
CRC immunology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Sarah Henrich 的研究动态
Follow Sarah Henrich's research updates
留下邮箱，当我们发布与 Sarah Henrich（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment